These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8814521)
1. AIDS-related obsessive compulsive disorder: deconditioning based on fluoxetine-induced inhibition of anxiety. Kraus RP; Nicholson IR J Behav Ther Exp Psychiatry; 1996 Mar; 27(1):51-6. PubMed ID: 8814521 [TBL] [Abstract][Full Text] [Related]
2. Obsessive-compulsive disorder. Diagnosis and management. Ladouceur R; Freeston M; Gagnon F Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492 [TBL] [Abstract][Full Text] [Related]
3. Treatment of obsessive compulsive disorder in the elderly: a review and case example. Calamari JE; Faber SD; Hitsman BL; Poppe CJ J Behav Ther Exp Psychiatry; 1994 Jun; 25(2):95-104. PubMed ID: 7983229 [TBL] [Abstract][Full Text] [Related]
4. Cognitive-behavioral therapy for children who have obsessive-compulsive disorder. Piacentini J; Langley AK J Clin Psychol; 2004 Nov; 60(11):1181-94. PubMed ID: 15389618 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of combination of fluoxetine and cognitive behavioral therapy and fluoxetine alone for the treatment of obsessive compulsive disorder. Giasuddin NA; Nahar JS; Morshed NM; Balhara YP; Sobhan MA Pak J Pharm Sci; 2013 Jan; 26(1):95-8. PubMed ID: 23261733 [TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. Simpson HB; Gorfinkle KS; Liebowitz MR J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder. Zitterl W; Meszaros K; Hornik K; Twaroch T; Dossenbach M; Zitterl-Eglseer K; Zapotoczky HG Wien Klin Wochenschr; 1999 Jun; 111(11):439-42. PubMed ID: 10420495 [TBL] [Abstract][Full Text] [Related]
9. Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder: a review and implications for interdisciplinary treatment. Abel JL Behav Res Ther; 1993 Jun; 31(5):463-78. PubMed ID: 8101439 [TBL] [Abstract][Full Text] [Related]
10. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade]. Prazeres AM; Souza WF; Fontenelle LF Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699 [TBL] [Abstract][Full Text] [Related]
14. An adolescent male with features of EDNOS and obsessive-compulsive disorder. Yanover T; Thompson JK; Straub DM Eat Weight Disord; 2008 Jun; 13(2):e20-4. PubMed ID: 18612248 [TBL] [Abstract][Full Text] [Related]
15. In-patient treatment for resistant obsessive-compulsive disorder. Al-Sughayir MA Saudi Med J; 2000 Feb; 21(2):193-5. PubMed ID: 11533781 [TBL] [Abstract][Full Text] [Related]
16. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]